Ask Pathology Geek
What should you look for when evaluating laboratory M&A?
Beyond standard financial due diligence, laboratory M&A requires deep analysis of LIS compatibility, payer contract retention, subspecialty alignment, and operational capacity.
IT and LIS Compatibility
The most common point of failure in lab mergers is IT integration. Combining two different Laboratory Information Systems (LIS) is a massive, expensive undertaking. Due diligence must assess whether one system will absorb the other, the cost of data migration, and the impact on client-facing EMR interfaces.
Payer Contracting
Acquiring a lab does not guarantee you keep their payer contracts. Many contracts have change-of-control provisions that allow payers to renegotiate or terminate. A thorough analysis of in-network status and the legal mechanisms for contract transition is mandatory.
Cultural and Clinical Alignment
Merging pathology groups requires aligning clinical cultures. Do the groups have similar thresholds for ordering ancillary testing? Do they use similar reporting templates? Misaligned clinical practices create friction among the pathologists and confusion for the ordering clinicians.
Key takeaways
- IT integration costs often destroy the anticipated financial synergies of a merger.
- Verify that crucial payer contracts will survive a change of control.
- Assess the clinical culture and diagnostic reporting styles of both groups.